Dysgraphia
Showing 1 - 25 of 35
Aphasia, Dysgraphia, Anomia Trial in United States (Treatment Focusing on Naming Objects, Treatment Focusing on Improving
Completed
- Aphasia
- +4 more
- Treatment Focusing on Naming Objects
- +3 more
-
Chicago, Illinois
- +3 more
Aug 9, 2021
Typical Development, Risk of Dysgraphia, Dysgraphia Trial in Évora (Graphomotor intervention program)
Completed
- Typical Development
- +2 more
- Graphomotor intervention program
-
Évora, PortugalHelena Isabel Falcão Coradinho
Mar 26, 2020
Typical Development, Risk of Dysgraphia, Dysgraphia Trial in Évora (Graphomotor intervention program)
Completed
- Typical Development
- +2 more
- Graphomotor intervention program
-
Évora, PortugalHelena Isabel Falcão Coradinho
Mar 26, 2020
Rhythmic Handwriting Deficits and General Rhythmic Abilities in
Not yet recruiting
- Developmental Coordination Disorder
-
Montpellier, FranceHôpital La Colombière - CHU de Montpellier
Aug 24, 2023
Fine Motor Function in Children With Specific Learning Disorders
Not yet recruiting
- Specific Learning Disorder
-
Antalya, TurkeyAkdeniz University
Jun 5, 2023
ADHD Trial in Nicosia (Music)
Recruiting
- Attention Deficit Hyperactivity Disorder
- Music
-
Nicosia, CyprusPrivate clinics
Jun 12, 2023
Developmental Dysgraphia Trial (SML, CON)
Completed
- Developmental Dysgraphia
- SML
- CON
- (no location specified)
Apr 6, 2019
Mild Cognitive Impairment, Primary Progressive Aphasia, Dementia Trial in Baltimore (Computerized Cognitive Training via
Recruiting
- Mild Cognitive Impairment
- +2 more
- Computerized Cognitive Training via BrainHQ
- Active tDCS (tDCS) on DLPFC
-
Baltimore, MarylandJohns Hopkins University
Aug 7, 2023
Primary Progressive Aphasia, Logopenic Progressive Aphasia, Non-Fluent Primary Progressive Aphasia Trial in Baltimore,
Not yet recruiting
- Primary Progressive Aphasia
- +2 more
- Active tDCS + Language Therapy
- Sham tDCS + Language Therapy
-
Baltimore, Maryland
- +2 more
Dec 14, 2022
Child Development Trial (Chinese character-based visuomotor training program, traditional visuomotor training program)
Not yet recruiting
- Child Development
- Chinese character-based visuomotor training program
- traditional visuomotor training program
- (no location specified)
Mar 20, 2023
3D Printing Writing Assisitive Device on Feasibility in Nerve
Not yet recruiting
- Nerve Injury
- 3D-printed writing aids task
-
New Taipei City, TaiwanTaipei Medical University Shuang Ho Hospital
Oct 18, 2022
Autism Spectrum Disorder, Asperger Syndrome Trial (High-intensity exercise, Wearable glove and arm sleeve device to measure
Not yet recruiting
- Autism Spectrum Disorder
- Asperger Syndrome
- High-intensity exercise
- Wearable glove and arm sleeve device to measure movement
- (no location specified)
Aug 17, 2022
Learning Disorder Trial in Trieste (Online enhancement training)
Completed
- Learning Disorder
- Online enhancement training
-
Trieste, ItalyIRCCS Burlo Garofolo
Apr 6, 2023
Relapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic Lymphoma Trial in Italy, United
Active, not recruiting
- Relapsed/Refractory Chronic Lymphocytic Leukemia and Relapsed/Refractory Small Lymphocytic Lymphoma
- brexucabtagene autoleucel
- +2 more
-
Phoenix, Arizona
- +21 more
Jun 2, 2022
Relapsed/Refractory Mantle Cell Lymphoma Trial in Worldwide (brexucabtagene autoleucel, Cyclophosphamide, Fludarabine)
Active, not recruiting
- Relapsed/Refractory Mantle Cell Lymphoma
- brexucabtagene autoleucel
- +3 more
-
Gilbert, Arizona
- +31 more
Jan 26, 2023
Generalized Tonic Clonic Seizures Trial in Worldwide (Pregabalin Dose Level 1, Pregabalin Dose Level 2, Placebo)
Completed
- Generalized Tonic Clonic Seizures
- Pregabalin Dose Level 1
- +2 more
-
Loxahatchee Groves, Florida
- +126 more
Jan 15, 2021
Locally Recurrent Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (NKTR-102, Treatment of Physician's Choice (TPC))
Completed
- Locally Recurrent Breast Cancer
- Metastatic Breast Cancer
- NKTR-102
- Treatment of Physician's Choice (TPC)
-
Flagstaff, Arizona
- +152 more
May 6, 2021
Acute Ischaemic Stroke, Transient Ischaemic Attack Trial in Worldwide (Ticagrelor, Placebo)
Completed
- Acute Ischaemic Stroke
- Transient Ischaemic Attack
- Ticagrelor
- Placebo
-
Adrogué, Argentina
- +387 more
Dec 21, 2020
Advanced Solid Tumors Trial in United States (ARRY-382, Pembrolizumab)
Terminated
- Advanced Solid Tumors
-
Los Angeles, California
- +29 more
May 21, 2022
HIV Trial in Worldwide (Raltegravir poloxamer film coated tablet, Raltegravir chewable tablet, Raltegravir oral granules for
Completed
- HIV Infections
- Raltegravir poloxamer film coated tablet
- +2 more
-
Alhambra, California
- +41 more
Oct 29, 2021
Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)
Active, not recruiting
- Breast Cancer
- Palbociclib
- Standard Adjuvant Endocrine Therapy
-
Mobile, Alabama
- +437 more
Mar 21, 2022
Colitis, Ulcerative Trial in Worldwide (Vedolizumab, Adalimumab , Adalimumab)
Treatment Resistant Depressive Disorder Trial in Belgium, Japan, United States (Esketamine 14 mg, Esketamine 28 mg, Esketamine
Completed
- Treatment Resistant Depressive Disorder
- Esketamine 14 mg
- +4 more
-
Birmingham, Alabama
- +24 more
May 18, 2020
Glioblastoma Multiforme Trial in United States (Cilengitide 500 mg, Cilengitide 2000 mg)
Completed
- Glioblastoma Multiforme
- Cilengitide 500 mg
- Cilengitide 2000 mg
-
Birmingham, Alabama
- +16 more
Jan 18, 2019